After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SMMT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Summit Therapeutics Inc is $13.70B. A total of 2.17 million shares were traded on the day, compared to an average of 4.10M shares.
In the most recent transaction, Xia Yu bought 533,617 shares of SMMT for 18.74 per share on Oct 21 ’25. After the transaction, the Director now owns 32,057,147 company shares. In a previous transaction on Oct 21 ’25, DUGGAN ROBERT W bought 26,680 shares at 18.74 per share. SMMT shares that Co-Chief Executive Officer owns now total 76,680.
Among the insiders who bought shares, Zanganeh Mahkam acquired of 26,680 shares on Oct 21 ’25 at a per-share price of $18.74. This resulted in the Co-Chief Executive Officer holding 76,680 shares of SMMT after the transaction. In another insider transaction, Zanganeh Mahkam bought 333,394 shares at $17.68 per share on Sep 10 ’25. Company shares held by the Co-Chief Executive Officer now total 556,088,090.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SMMT has a high of $36.91 and a low of $15.55.
As of this writing, SMMT has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $0.76 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.06 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.26, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 4.25.
